Clinical Trials

Featured Clinical Trials

• Commentary
• Landmark

• CURRENT–OASIS 7
  Title:	Clopidogrel and Aspirin Optimal Dose Usage to Reduce Recurrent Events−Seventh Organization to Assess Strategies in Ischemic Syndromes
  Year:	2010

  Clinical Trial:	CILostazol-based triple anti-platelet therapy ON Ischemic Complication after drug-eluting stenT implantation

• AASK
  Title:	African American Study of Kidney Disease and Hypertension
  Year:	2010

• FUTURA OASIS 8
  Title:	A Randomized Trial Comparing Two Regimens of Adjunctive Intravenous UFH During PCI in High-Risk Patients With NSTE-ACS Treated With Fondaparinux
  Year:

  Clinical Trial:	OASIS 5

• ANTIPAF
  Title:	Angiotensin II-Antagonist in Paroxysmal Atrial Fibrillation
  Year:

• DANPACE
  Title:	Danish Multicenter Randomised Trial on Single-Lead Atrial Versus Dual-Chamber Pacing in Sick Sinus Syndrome
  Year:

• EINSTEIN DVT
  Title:	Oral Rivaroxaban Versus Standard Therapy in the Initial Treatment of Symptomatic Deep Vein Thrombosis and Long-Term Prevention of Recurrent Venous Thromboembolism
  Year:

• AVERROES
  Title:	Apixaban Versus Acetylsalicylic Acid to Prevent Strokes
  Year:

• ART
  Title:	Arterial Revascularization Trial
  Year:

• ATOLL
  Title:	Acute STEMI Treated With Primary PCI and Intravenous Enoxaparin or UFH to Lower Ischemic and Bleeding Events at Short- and Long-Term Follow-Up
  Year:

• INNOVATE PCI
  Title:	Intravenous and Oral Elinogrel, a Selective and Reversible P2Y12 Receptor Inhibitor in Patients Undergoing Nonurgent PCI
  Year:

• J-LANCELOT
  Title:	Japanese-Lesson from Antagonizing the Cellular Effect of Thrombin
  Year:

• PEARL HF
  Title:	Parallel Evaluation of RLY5016 in Heart Failure
  Year:

• SHIFT
  Title:	Systolic Heart failure treatment with the IF inhibitor ivabradine Trial
  Year:	2010

• ALPHA OMEGA
  Title:	Effect of Low Doses of N-3 Fatty Acids on Cardiovascular Diseases in Post-MI Patients
  Year:

• HEBE III
  Title:	A Single Dose of Erythropoietin in ST-Elevation Myocardial Infarction
  Year: